topic: Access to Medicines

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
MSF's Mobile Response Team: Bringing Mental Health Support to Kashmir
MSF’s Mobile Response Team: Bringing mental health support to Kashmir
MSF enhancing mental health care in Kashmir
Bringing mental health care to Kashmir
MSF's Mobile Response Team: Bringing Mental Health Support to Kashmir
India: Bringing mental health support to Kashmir
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
MSF South Asia Health and Humanity Summit: Partnering to build better responses during emergencies
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics